BioHarvest Sciences (BHST) Stock Price, Quote, News & History

Comments

BioHarvest Sciences Inc (BHST) Stock Price, Quote, News & History

BHSTNASDAQ

Trade with Public

$4.31

0.030.70%

At close: Apr 10, 5:00 PM EST

$4.35

0.040.93%

After Hours: Apr 8, 7:03 AM EST

OverviewNews Earnings Guidance Analyst Ratings Short Interest Stock Report

Key Statistics

Open

$4.36

Close

$4.31

Volume / Avg.

17.79K / 27.77K

Day Range

$4.28 - $4.50

52 Wk Range

4.10 - 12.80

Market Cap

$98.61M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

0.34%

Days to Cover

3.97

Recent BioHarvest Sciences Inc News

EXCLUSIVE: Botanical Synthesis Tech-Focused BioHarvest's First Synthetic Olive Cells Shows Reduced Fat Accumulation in Liver Cells

BioHarvest's olive cell compound, rich in Verbascoside, showed promising results in reducing fat accumulation in liver cells, with a 2026 market launch planned.

Vandana Singh

EXCLUSIVE: BioHarvest Collaborate With Tate & Lyle To Develop Proprietary Plant-Based Molecules

Tate & Lyle and BioHarvest Sciences partner to develop sustainable and affordable plant-based molecules for food and beverage industry.

Anusuya Lahiri

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-7.23M

Investing Cash Flow (TTM)

-2.37M

Financing Cash Flow (TTM)

30.19M

Free Cash Flow (TTM)

-9.58M

Capital Expenditure (TTM)

-2.36M

Net Change in Cash (TTM)

20.60M

Analyst Trends and Forecast

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$88.78M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.28

PB Ratio (TTM)

3.81

Earnings Yield % (TTM)

-14.02%

Earnings Yield % (FWD)

-10.51%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.12

Company Debt

Total Debt

$2.57M

LT Debt

$2.42M

LT Debt Issuance (TTM)

$12.40M

LT Debt Repayment (TTM)

-$7.15M

Total Cash

$23.03M

Debt to Equity

0.55

Issuance of Debt (TTM)

$5.25M

Repayment of Debt (TTM)

-$7.15M

Key Statistics

Open

$4.36

Close

$4.31

Volume / Avg.

17.79K / 27.77K

Day Range

$4.28 - $4.50

52 Wk Range

4.10 - 12.80

Market Cap

$98.61M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

0.34%

Days to Cover

3.97

About

Sector

Consumer Staples

Industry

Personal Products

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying t...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy BioHarvest Sciences (BHST) stock?

A

You can purchase shares of BioHarvest Sciences (NASDAQ:BHST) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BioHarvest Sciences (BHST) competitors?

A

Other companies in BioHarvest Sciences’s space includes: Olaplex Holdings Inc (NASDAQ:OLPX), Herbalife Ltd (NYSE:HLF), AXIL Brands Inc (AMEX:AXIL), The Honest Co Inc (NASDAQ:HNST) and ODDITY Tech Ltd (NASDAQ:ODD).

Q

What is the forecast, or price target, for BioHarvest Sciences (BHST) stock?

A

BioHarvest Sciences has a consensus price target of $12.00.

Q

What is the current price for BioHarvest Sciences (BHST)?

A

The stock price for BioHarvest Sciences (NASDAQ: BHST) is $4.35 last updated April 8, 2026 at 7:03 AM EDT.

Q

Does BioHarvest Sciences (BHST) pay a dividend?

A

There are no upcoming dividends for BioHarvest Sciences.

Q

When is BioHarvest Sciences (NASDAQ:BHST) reporting earnings?

A

BioHarvest Sciences does not have any upcoming earnings scheduled.

Q

Is BioHarvest Sciences (BHST) going to split?

A

There is no upcoming split for BioHarvest Sciences.

Q

What sector and industry does BioHarvest Sciences (BHST) operate in?

A

BioHarvest Sciences is in the Consumer Staples sector and Personal Products industry. They are listed on the NASDAQ.

People Also Watch

Natures Sunshine Products Inc

NASDAQ:NATR

$27.05

0.45%

Key Statistics

Open

$4.36

Close

$4.31

Volume / Avg.

17.79K / 27.77K

Day Range

$4.28 - $4.50

52 Wk Range

4.10 - 12.80

Market Cap

$98.61M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

0.34%

Days to Cover

3.97

Recent BioHarvest Sciences Inc News

EXCLUSIVE: Botanical Synthesis Tech-Focused BioHarvest's First Synthetic Olive Cells Shows Reduced Fat Accumulation in Liver Cells

BioHarvest's olive cell compound, rich in Verbascoside, showed promising results in reducing fat accumulation in liver cells, with a 2026 market launch planned.

Vandana Singh

EXCLUSIVE: BioHarvest Collaborate With Tate & Lyle To Develop Proprietary Plant-Based Molecules

Tate & Lyle and BioHarvest Sciences partner to develop sustainable and affordable plant-based molecules for food and beverage industry.

Anusuya Lahiri

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-7.23M

Investing Cash Flow (TTM)

-2.37M

Financing Cash Flow (TTM)

30.19M

Free Cash Flow (TTM)

-9.58M

Capital Expenditure (TTM)

-2.36M

Net Change in Cash (TTM)

20.60M

Analyst Trends and Forecast

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$88.78M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.28

PB Ratio (TTM)

3.81

Earnings Yield % (TTM)

-14.02%

Earnings Yield % (FWD)

-10.51%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.12

Company Debt

Total Debt

$2.57M

LT Debt

$2.42M

LT Debt Issuance (TTM)

$12.40M

LT Debt Repayment (TTM)

-$7.15M

Total Cash

$23.03M

Debt to Equity

0.55

Issuance of Debt (TTM)

$5.25M

Repayment of Debt (TTM)

-$7.15M

Key Statistics

Open

$4.36

Close

$4.31

Volume / Avg.

17.79K / 27.77K

Day Range

$4.28 - $4.50

52 Wk Range

4.10 - 12.80

Market Cap

$98.61M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

0.34%

Days to Cover

3.97

About

Sector

Consumer Staples

Industry

Personal Products

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying t...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry